Form D · Other

Snap Infusion LLC

Andover, MA · CIK 0001513760

Offering snapshot reported Apr 28, 2015 · SEC filing

Reported sold
$200K
Offering amount: $784K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 22, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 28, 2015Initial$200,000No comparison1SEC filing
Nov 24, 2014Initial$1,500,000No comparison1SEC filing
Jun 26, 2014Initial$610,818No comparison3SEC filing
Feb 11, 2014Amendment$1,500,000No comparison1SEC filing
Dec 24, 2013InitialYet to sellNo comparison0SEC filing
Mar 27, 2012Initial$100,000No comparison5SEC filing
Feb 25, 2011Initial$425,000No comparison2SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-238734

Source: Form D, filed Apr 28, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Bax Director
Andres Bernal Correa Promoter
Ted Gage Director
Edward Gage Director
John Johnson Director
John Jonson Director
Miguel Moreno Director
Eric Stoll Director, Executive
Andrea Stoll Director, Executive
Matthew Tucker Director

Issuer details

Industry: Other (See others in industry)

Address:
29 Dundee Park Drive Suite 102
Andover, MA, 01810